Schedule 13G ownership disclosure

Fate Therapeutics Inc

Security class unavailable · CUSIP: 31189P102

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
66,559,621
Percent of class
12.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001425738-18-000008
Form type
SC 13G/A
Filer
FATE THERAPEUTICS INC
CIK
CIK 1434316
Filed
Feb 14, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub